CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net income (loss)	$ 177,521	$ (48,441)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and other amortization	37,859	53,599
Deferred tax provision (benefit)	336	(11)
Realized investment gains, excluding impairment losses	(923)	(3,933)
Net investment impairment losses	0	328
Loss on repurchases of senior notes	837	0
Other	29,132	(3,235)
Change in certain assets and liabilities:
Accrued investment income	1,177	(7,007)
Prepaid reinsurance premium	(7,987)	(7,974)
Reinsurance recoverable on loss reserves	6,187	34,227
Reinsurance recoverable on paid losses	3,975	1,228
Premium receivable	1,971	2,566
Deferred insurance policy acquisition costs	(1,929)	(1,273)
Profit commission receivable	(66,584)	(2,938)
Loss reserves	(533,819)	(703,849)
Premium deficiency reserve	(19,750)	(16,746)
Unearned premiums	31,513	10,529
Income taxes payable (current)	(1,180)	314
Net cash used in operating activities	(341,664)	(692,616)
Cash flows from investing activities:
Purchase of fixed maturities	(1,549,883)	(2,669,778)
Purchase of equity securities	(59)	(69)
Proceeds from sale of fixed maturities	902,660	602,062
Proceeds from maturity of fixed maturities	914,465	1,120,152
Net increase in payable for securities	7,245	317
Net change in restricted cash	233	(60,348)
Net cash provided by (used in) investing activities	274,661	(1,007,664)
Cash flows from financing activities:
Net proceeds from convertible senior notes	0	484,625
Common stock shares issued	0	663,335
Repurchases of long-term debt	(21,767)	(17,235)
Net cash (used in) provided by financing activities	(21,767)	1,130,725
Net decrease in cash and cash equivalents	(88,770)	(569,555)
Cash and cash equivalents at beginning of period	332,692	1,027,625
Cash and cash equivalents at end of period	$ 243,922	$ 458,070